Trial
NCT02637466
Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
Takeda
Condition
Unipolar Major Depression
Intervention
Vortioxetine
Why stopped
Funding not received
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-30